Latest News

Terumo Heart, Inc. announced today that they have received conditional approval from the Food and Drug Administration (FDA) to begin enrollment in the US Pivotal Trial of the DuraHeart ^TM LVAS for a Bridge-to-Transplant (BTT) indication. More.>>